Title: HOVON-65/GMMG-HD4 Randomized Phase III Trial Comparing Bortezomib, Doxorubicin, Dexamethasone (PAD) Vs VAD Followed by High-Dose Melphalan (HDM) and Maintenance with Bortezomib or Thalidomide In Patients with Newly Diagnosed Multiple Myeloma (MM)
Authors: Sonn-Eveld, Pieter
Schmidt-Wolf, Ingo
van der Holt, Bronno
el Jarari, Laila
Bertsch, Uta
Salwender, Hans
Zweegman, Sonja
Vellenga, Edo
Schubert, Joerg
Blau, Igor Wolfgang
Jie, Asiong
Beverloo, Berna
Hose, Dirk
Jauch, Anna
van de Velde, Helgi
Schaafsma, Martijn
Lindemann, Walter
Kersten, Marie Jose
Duehrsen, Ulrich
Delforge, Michel
Weisel, Katja
Croockewit, Sandra
Martin, Hans
Wittebol, Shulamit
Scheid, Christof
Bos, Gerard
van Marwijk-Kooy, Marinus
Wijermans, Pierre
Lokhorst, Henk
Goldschmidt, Hartmut #
Issue Date: Nov-2010
Publisher: Amer soc hematology
Host Document: Blood vol:116 issue:21 pages:23-24
Conference: 52nd Annual Meeting of the American-Society-of-Hematology (ASH) Orlando, FL, DEC 04-07, 2010
ISSN: 0006-4971
Publication status: published
KU Leuven publication type: IMa
Appears in Collections:Embryo and Stemcells (-)
# (joint) last author

Files in This Item:

There are no files associated with this item.


All items in Lirias are protected by copyright, with all rights reserved.